oncotherapy

oncotherapy

 [ong″ko-ther´ah-pe]
the treatment of tumors.

on·co·ther·a·py

(ong'kō-ther'ă-pē),
Treatment of tumors.

oncotherapy

(ŏng″kō-thĕr′ă-pē) [″ + therapeia, treatment]
The treatment of tumors.

oncotherapy

the treatment of tumors.
References in periodicals archive ?
Eisai focuses its efforts in three therapeutic areas: integrative neuroscience, including neurology and psychiatric medicines; integrative oncology, which encompasses oncotherapy and supportive-care treatments; and vascular/immunological reaction.
Contract notice: Purchase a variety of consumables oncotherapy the University of Pcs in the framework of the framework agreement during the 24 month period , 22 tender part .
Most of [all] in oncotherapy, NeoBiocon has the second-largest chemotherapy brand in UAE with a market share of 31 per cent and is among the top 15 oncology companies in the UAE.
20 November 2015 - UK-based Advanced Oncotherapy Plc (AIM: AVO), a developer of proton therapy systems for cancer treatment, announces has disposed of its subsidiary, Oncotherapy Resources Ltd for a total cash consideration of GBP 100,000 (USD 152,800), the company said.
M2 EQUITYBITES-November 20, 2015-Advanced Oncotherapy Sells Oncotherapy Resources
Product Pipeline Review - 2015', provides an overview of the OncoTherapy Science, Inc.
announces that the exclusive licensing contract that has been in effect with OncoTherapy Science, Inc.
Companies Mentioned in this Report: Hitachi, IBA Proton Therapy, Mitsubishi Electric, Varian Medical Systems, Accuray, Advanced Oncotherapy, Advanced Particle Therapy, Advanced Proton Solutions, Best Particle Therapy, Compact Particle Acceleration, Elekta, GE Healthcare, Mevion Medical Systems, Optivus ProtonTherap, Procure Treatment Center, ProNova Solutions, ProTom International, SAH Global, Siemens, Sumitomo Heavy Industries, Toshiba
Brown has been an investor in equities and real estate for more than 30 years, is currently a non-executive director of Feedback Plc and was, until recently, a director of Advanced Oncotherapy Plc, where he was involved in the strategy of transition to the provision of advanced cancer treatment services.
M2 PHARMA-April 24, 2013-Advanced Oncotherapy plans to acquire CERN spin-off ADAM(C)2013 M2 COMMUNICATIONS
Senior Specialist, Department of Oncotherapy, Universitas Hospital, University of the Free State, Bloemfontein